Invention Grant
- Patent Title: Crystalline form of a 3-phenoxymethylpyrrolidine compound
- Patent Title (中): 结晶形式的3-苯氧基甲基吡咯烷化合物
-
Application No.: US14313422Application Date: 2014-06-24
-
Publication No.: US09120746B2Publication Date: 2015-09-01
- Inventor: Daisuke Roland Saito
- Applicant: Daisuke Roland Saito
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah
- Main IPC: C07D207/08
- IPC: C07D207/08 ; A61K31/40 ; A61K45/06
Abstract:
The invention provides a crystalline hydrochloride salt of (S)-3-[(S)-1-(4-chlorophenoxy)-2-methylpropyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.
Public/Granted literature
- US20150080450A1 CRYSTALLINE FORM OF A 3-PHENOXYMETHYLPYRROLIDINE COMPOUND Public/Granted day:2015-03-19
Information query
